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ABSTRACT 
A ten year study of malaria amongst paediatric patients was carried out in the Federal Capital Territory, Nigeria, West Africa 
from 2000 to 2010. Giemsa staining methodology was used. Of the 24 289 blood samples analyzed (comprising of 13 435 male 
children and 10 854 female children), 8668 (35·7%) were positive for malaria parasites. 267 (3·1%) had parasite density of > 5000 
parasites/µl of blood; 382 (4·4%) had between 500 - 5000 parasites/µl of blood; 1262 (14·6%) had between 50 - 500 parasites/µl of 
blood; while 6757 (77·9%) had between 5 - 50 parasites/µl of blood. The 11-15 years age group had the highest prevalence of 
40·6%, while neonates (<1 - 28 days), 1 month – 5 years, and 6 – 10 years age groups recorded 27·2%, 34.5% and 36·5% 
respectively. Of the 13 435 male children, 4845 (36·1%) had positive malaria result as against 35·2% (3823) of positive cases 
recorded among the 10854 female children. There is need to enhance parasitological diagnosis by way of providing diagnostic 
tolls at all levels of health care – primary (rural settings), secondary and tertiary. There are negative implications associated with 
the continued use of malaria rapid diagnostic tests (M-RDTs) methodologies which includes underdiagnosis, misdiagnosis of 
malaria and mismanagement of non-malarial fever, which wastes limited resources, erodes confidence in the health care system, 
and contributes to drug resistance. Finally, appropriate antimalarial drugs for treatment should be given free to all malaria 
positive children. 
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INTRODUCTION 
The bare facts are that malaria is a public health 
problem in more than 90 countries inhabited by 40% 
of the world’s population and that there are 300 – 500 
million cases annually with a mortality of 1·5 – 2·7 
million, mainly children in Africa. Malaria infections 
produce the most severe disease in those with the 
least immunity. 90 % of the world’s malaria is 
transmitted in the sub-Saharan Africa, and immunity 
is acquired over time, requiring repeated exposure to 
the bites of infective Anopheles mosquitos. As a 
result, young African children are the group at 
highest risk of developing severe disease. Patwari 
(1985) (1) reported malaria accounting for between 5 – 
15% of deaths of children in endemic areas. However, 
ten years later, Defo (1995) (2) reported 20 – 30% of 
deaths in childhood being attributed to malaria.  
Based on documented cases, the WHO estimates that 
there were 219 million cases of malaria in 2010 
resulting in 660 000 deaths (3). This is equivalent to 
roughly 2000 deaths every day (4). A 2012 study 
estimated the number of documented and  
 
undocumented deaths in 2010 was 1·24 million. The 
majority of cases (65%) occur in children under 15 
years old (5, 6). Pregnant women are also especially 
vulnerable: about 125 million pregnant women are at 
risk of infection each year. In Sub-Saharan Africa, 
maternal malaria is associated with up to 200 000 
estimated infant deaths yearly (7). 
In Nigeria, the disease is responsible for 60% of 
outpatient visits to health facilities, 30% childhood 
deaths, 25% of death in children under one year and 
11% maternal death (8). WHO estimates there were 
655 000 malaria deaths in 2010, 91% in the African 
Region, and 86% were children under 5 years of age. 
More cases of malaria in the neonatal period are being 
reported which may be due to congenital malaria 
through transplacental infection, malaria acquired 
postnatally from mosquito bites or exchange 
transfusion (9, 10). 
The problem of malaria had not abated though; 
Artemisinim-combination therapy (ACT) drugs are in 
circulation in the drug market aimed at taking care of 




The objective of this study therefore is to determine 
the burden of malaria amongst paediatric patients in 
the Federal Capital Territory, Nigeria. 
METHODS 
        Study Area  
The Federal Capital Territory (FCT), Abuja is the 
study area. Abuja is located between latitude 8·25 and 
9·20 north of the Equator and longitude 6·45 and 7·39 
east of the Greenwich Meridian. The Federal Capital 
Territory has a total landmass of about 8000 sq kms; 
located geographically at the centre of the country. 
The current population size of the FCT according to 
the 2006 census figures stands at 1 405 201 (11). 
Two seasons are experienced in FCT. These are the 
wet (rainy) season and the dry season. The rainy 
season lasts between April to October (with a mean 
total rainfall of 62·8 – 262·7 mm; August being the 
highest). The dry season is between November and 
March (with a mean total rainfall of 1·2 to 11·3 mm). 
Abuja has a daily temperature range between 20·4 – 
34·7oc with an average of 27·2oc/81of in January; and 
between 21·9 – 29·1oC with an average of 25·6oc/78of 
in July (12). 
Study Population 
The population studied consisted of 24 289 children 
(comprising of 13 435 males and 10 854 females) 
whose age ranged from day of birth to 15 years whose 
blood samples were processed at the Parasitology 
Laboratory of National Hospital, Abuja for malaria 
parasite diagnosis. This study was carried out from 
May 2000 to December, 2010. 
Parasitological Techniques 
Thick and thin blood films were made on clean 
grease-free slides and stained appropriately using 
Giemsa’s staining method. The stained films were 
then examined microscopically using 100x objective 
to count the parasites. 
Parasites were counted by estimating the parasite 
numbers/µl of blood from the thick film. This was 
carried out by multiplying the average number of 
parasites per thick film fields (100x objective) by 500. 
Between 10 -100 fields (depending on parasiteamia) 
were examined to determine the average number of 
trophozoites per thick film fields. Ten fields are 
sufficient when the parasite density is high.  
The factor of 500 was proposed by Greenwood and 
Armstrong (1991) (13). They calculated that 5 - 8 µl is 
the volume of blood required to make a satisfactory 
thick film and that the volume of blood in one thick 
film fields (100 x objectives) of a well-prepared thick 
film is about 0.002µl. Therefore the number of 
parasites per thick film field multiplied by 500 gives 
the estimated number of parasites/µl of blood.  
This method, Greenwood and Armstrong (1991) (13) 
found to be more accurate and quicker than counting 
the parasites against 100 white blood cells in a thick 
film using WHO method as used by Molineaux and 
Gramiccia (1980) (14). In 2002, Ikeh et al, (15) used this 
technique in their study at Jos. 
For designation of the relative parasite count on a 
thick film, a simple code of from one to four crosses 
or the plus sign scheme is used to report parasite 
numbers: 
• +      (1+)      =   1 – 10    parasites per 100 thick          
film fields  
• + +   (2+)      = 11 – 100  parasites per 100 thick 
film fields 
• + + +  (3+)    =   1 – 10    parasites per one thick 
film field 
• + + + +  (4+) =     > 10     parasites per one thick 
film field 
RESULTS 
Of the 24 289 samples analyzed, 8668 (35·7%) were 
positive for malaria parasites. 267 (3·1%) had parasite 
density of > 5000 parasites/µl of blood (4+); 382 
(4·4%) had between 500-5000 parasites/µl of blood 
(3+); 1262 (14·6%) had between 50-500 parasites/µl of 
blood (2+); while 6757 (77·9%) had between 5-50 
parasites/µl of blood (1+) as shown  
The 11-15 years age group had the highest prevalence 
of 40·6%, while neonates (<1 - 28 days), 1 month – 5 
years, and 6 – 10 years recorded 27·2%, 34·5% and 
36·5% respectively. The parasite density of each age 
group is shown in table 1. 
Of the 13 435 male children, 4845 (36·1%) had positive 
malaria result as against 35·2% (3823) positive cases 







TABLE I: PREVALENCE AND PARASITE INTENSITY OF ALL CHILDREN
 
Age Group       4+             3+        
     
Neonates      0(0%)              2(0·6%)       51(14·
1mth – 5years      108(1·9%)       166(3·0%)      759(13·7%)       4510(81·4%)       5543(34·9%)    10362                15905
6 – 10 years           77(5%)            91(5·9%)      233(15
11 – 15 years        82(6·7%)       123(10·1%)      219(18%)           797(65
Total              267(3·1%)      382(4·4%)      1262(14
Key: 4+  => 5000 parasites/µl of blood; 3+ =    500 









Figure I: % Prevalence Rate of all children
6 - 10 
years, 17.80%
11 - 15 years, 14.10%
Figure II: % Positivity of all age groups
 
 
 2+        1+                    Total                  Negatives          Total No. 
                  Positives                                       
2%)         306(85·2%)        359(26%)           1022                  1381
·1%)       1144(74%)          1545(38·3%)      2484                  4029 
·3%)       1221(41·1%)      1753                  2974 
·6%)     6757(77·9%)       8668(35·7%)      15621               
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TABLE II:  PREVALENCE AND 
Age Group   4+           3+     
     
Neonates      0(0%)                1(0·5%)        29(15·5%)         158(84%)         188(25%)          565            753
1mth – 5years   65(2·1%)        91(2·9%)      443(14·2%)       2528(80·8%)     3127(35·1%)     5783           8910
6 – 10 years      49(5·6%)        56(6·4%)      133(15·2%)        636(72·8%)        874(40%)        1315           2189
11 – 15 years    52(7·9%)        75(11·4%)    112(17
Total                       166(3·4%)     223(4·6%)      717(14
Key: 4+ - > 5000 parasites/µl of blood; 3+ -    
1+ -    5 – 50 parasites/µl of blood 
FIGURE III: % PARASITE DENSITY OF MALE CHILDREN



























PARASITE INTENSITY OF MALE CHILDREN 
 2+           1+                Total         Negatives  Total No. 




·1%)        417(63·6%)        656(41·4%)       927           1583 
·8%)      3739(77·2%)        4845(36·1%)   8590         13435 




























TABLE III:  PREVALENCE AND PARASITE INTENSITY OF FEMALE CHILDREN
Age Group   4+         3+                
     
Neonates     0(0%)                 1(0·9%)           22(12·9%)      148(86·5%)        171(27·2%)                 457            628
1mth – 5years   43(1·8%)         75(3·1%)        316(13·1%)     1982(82%)            2416(34·5%)            4579           
6 – 10 years      28(4·2%)          35(5·2%)          100(15%)      508(75·7%)          671(36·5%)               1169  
11 – 15 years    30(5·3%)          48(8·5%)        107(19%)          380(67
Total                 101(2·6%)        159(4·2%)      545(14·3%)      3018(78·9%)      3823(35·2%)            
Key: 4+ = > 5000 parasites/µl of blood; 3+ = 500 – 5000 parasites/µl of blood; 2+ =   50 
FIGURE V
































Neonates 1 mnth-5 years
 
2+        1+                            Total          Negatives   Total No. 
          Positives            Examined
 
         
·3%)        565(40·6%)                826           1391
  7031        10854
– 500 parasites/µl of blood; 1+ =   5 – 50 parasites/µl of blood
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This study highlights the importance of prompt and 
accurate parasitological diagnosis of malaria amongst 
the paediatrics. Malaria parasites were found in 35·7% 
of all age groups.  
In 1971, Hendrickse et al (16) reported a 33·3% 
prevalence rate in their study in Ibadan, Western 
Nigeria (now, South West Nigeria). In 1993, Pam et al, 
(17) reported a 41% prevalence rate for malaria 
among children that attended maternal and child 
welfare clinics in northern Nigeria. Ikeh et al, (2002) 
(15) had reported 29·3% positivity among paediatric 
patients in Jos. In 2006, Runsewe-Abiodun et al, (18) 
reported 24·8% malaria positivity among neonates 
and 17·4% for congenital malaria at Sagamu, Ogun 
State, South-west Nigeria. Oyedeji et al, (2010) (19) in 
their report stated that 20·3% of paediatrics had 
positive malaria test at Osogbo, South-West Nigeria. 
All these reports indicate that Nigeria is a 
mesoendemic country having a stable transmission 
being based on the WHO classification of endemicity 
revised by Metselaar and Van Thiel (1959) (20).   
However, Okogun & Amadi (2005) (21) reported that 
95·2% of paediatric patients were confirmed positive 
for malaria parasites microscopically at a Nigerian 
tertiary health institution. We have not seen any other 
report that supports such very high percentage 
positivity among paediatrics in Nigeria. 
In this study, although, the 1 month – 5 years age 
group (under fives) had most of the samples 
analyzed, 15,905 (65·5%) of the 24,289; it had a % 
positivity of 34·9%. The 11 – 15 years age group had 
the highest % positivity of 41·1%, though with the 
second to last total number of samples examined, 
2,974 (12·2%). From our data, it showed that a greater 
number of the blood samples analyzed (71·2%) were 
those of the under fives including the neonates. This 
indicates that this group is more vulnerable or more 
hospital bound due to their low immune status than 
the older children between 6 – 15 years. 26% of 
neonates had malaria positivity rate while of the 6 – 
10 years age group a % positivity of 38·3% was 
recorded. 
The highest % positivity of 41·1% among the 11 – 15 
years age group may be attributed to the theory of 
innate immunity (9). In 2002, Ikeh et al, (15) reported 
38·1% positivity amongst this age group. 
The parasitaemia among neonates in this study - 26%, 
most likely represents first infection and a good 
indication of recent transmission of malaria through 
transplacental infection or blood transfusion. We did 
not differentiate between congenital malaria from 
other neonatal malaria because we could not lay our 
hands on the folders of these patients as to identify 
those that had exchange blood transfusion.  
In this study, no significant differences were found in 
prevalence and % positivity in relation to gender. 
While the male children had a % positivity of 36·1%, 
the female children had 35·2%. 
Meanwhile, the continued use of malaria rapid 
diagnostic tests (M-RDTs) methodologies in Nigeria 
for individual diagnosis of malaria should be highly 
discouraged because of its negative implication. The 
implication of the continued use of these malaria 
rapid diagnostic tests (M-RDTs) methodologies 
includes underdiagnosis, misdiagnosis of malaria, 
mismanagement of non-malarial fever, which wastes 
limited resources, erodes confidence in the health care 
system, contributes to drug resistance, and eventual 
administration of unnecessary antimalarial drugs 
aimed at mopping up all negative test results where 
patients may still present with symptoms. 
Several studies have shown that malaria rapid 
diagnostic tests (M-RDTs) methodologies have 
malaria parasites detection limit of 397 – 500 
parasites/µl of blood and in some cases even more 
than 500 parasites/ µl of blood (22, 23, 24, 25, 26, 27, 
28) as against the 5 parasites/µl of blood detectable 
with the Giemsa stained slide microscopy examined 
by microscopists who are experienced and competent 
in the preparation and staining of blood films, as well 
as in the recognition and identification of the 
characteristic stages of malaria parasites usually 
found in human blood.  
Conclusion 
The missing component of the Roll Back Malaria 
(RBM) strategy - Laboratory Diagnosis should be 
incorporated. The vision of the current five-year 
strategic plan (2009 – 2013) is to ensure that Malaria 
no longer becomes a major public health problem in 
Nigeria as illness and death from malaria gets 
significantly reduced. This is to be achieved by 
ensuring that families will have universal access to 
malaria prevention and treatment. This latter aspect 
should rather read “access to malaria prevention, 
laboratory diagnosis and treatment. 
There is need to enhance parasitological diagnosis by 
way of providing diagnostic tolls (both man-power 
and materials) at all levels of health care – primary 
(rural settings), secondary and tertiary. Above all, the 
turn-around time for malaria parasitological 
diagnosis should be drastically reduced so that such 
patients get their results same day and those with 




treatment before going back home. Appropriate 
antimalarial drugs for treatment should be given free 
to all malaria positive children.  
Finally, if we must win this war against malaria, all 
unnecessary politicking associated with the 
prevention, accurate diagnosis at all levels of 
healthcare and effective treatment must be put aside.  
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